Biogen (original) (raw)
Latest News for: biogen
Statement of Changes in Beneficial Ownership (Form 4) (Biogen Inc)
Public Technologies 11 Jun 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... BIOGEN INC ... BIOGEN INC., 225 BINNEY ST ... BIOGEN INC ... Biogen Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
PR Newswire 11 Jun 2026
NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ ... The investigation concerns whether Biogen and ...
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
Nasdaq Globe Newswire 10 Jun 2026
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm ... .
Proxy Results (Form 8-K) (Biogen Inc)
Public Technologies 10 Jun 2026
) Item 5.07 Submission of Matters to a Vote of Security Holders. On June 9, 2026, Biogen Inc. (the "Company") held its 2026 Annual Meeting of Stockholders. The final voting results for this meeting are as follows. 1 ... Maria C. Freire ... 2 ... Biogen Inc.
Amendment to Current Report (Form 8-K/A) (Biogen Inc)
Public Technologies 10 Jun 2026
Biogen Inc ... On May 14, 2026, Biogen Inc., a Delaware corporation ("Biogen"), filed a Current Report on Form 8-K (the "Original Report") with the U.S ... Biogen ... Biogen Inc ... Biogen Inc.
Lost Money on Biogen Inc. (BIIB)? Contact The Gross Law Firm Regarding an Ongoing Investigation
Nasdaq Globe Newswire 05 Jun 2026
NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. ... .
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses (Biogen Inc)
Public Technologies 03 Jun 2026
). The text version of this document is not available ... Disclaimer. Biogen Inc.
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
Nasdaq Globe Newswire 03 Jun 2026
CAMBRIDGE, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Biogen Inc.�(Nasdaq ...
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 ...
Nasdaq Globe Newswire 01 Jun 2026
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- UCB�(Euronext Brussels. UCB) and�Biogen Inc.�(Nasdaq.
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus (Biogen Inc)
Public Technologies 01 Jun 2026
From time to time, we have used, or expect in the future to use, our investor relations website (investors.biogen.com), the Biogen LinkedIn account (linkedin.com/company/biogen-) and the Biogen X ...
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus (UCB SA)
Public Technologies 01 Jun 2026
From time to time, we have used, or expect in the future to use, our investor relations website (investors.biogen.com), the Biogen LinkedIn account (linkedin.com/company/biogen-) and the Biogen X ...
Biogen Inc. (BIIB) Investors with Losses are Urged to Contact The Gross Law Firm to ...
Nasdaq Globe Newswire 29 May 2026
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. ... .
Biogen Inc. (BIIB) Investors with Losses are Urged to Contact The Gross Law Firm to Discuss
Caledonian Record 29 May 2026
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. ....
Biogen Announces Webcast of Annual Meeting of Stockholders (Biogen Inc)
Public Technologies 28 May 2026
Biogen Announces Webcast of Annual Meeting of Stockholders ... - Biogen Inc ... About Biogen ... We routinely post information that may be important to investors on our website at www.biogen.com ... Investor Relations Biogen 781.464.2442 ... Biogen Inc.
Creative Biogene Supports Transforming Cell Therapy with In Vivo RNA-based CAR-T Development Solutions
Pharmiweb 28 May 2026
Creative Biogene is a dedicated research solutions provider focused on developing cutting-edge platforms for cancer therapy and preclinical studies ... Creative Biogene offers ... About Creative Biogene.